Dengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral Serotypes.
Dengue virus (DENV) infection is a major emerging disease widely distributed throughout the tropical and subtropical regions of the world affecting several millions of people. Despite constants efforts, no specific treatment or effective vaccine is yet available. Here we show a novel design of a DNA...
Saved in:
Main Authors: | Monica Poggianella (Author), José L Slon Campos (Author), Kuan Rong Chan (Author), Hwee Cheng Tan (Author), Marco Bestagno (Author), Eng Eong Ooi (Author), Oscar R Burrone (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein.
by: Yadunanda Budigi, et al.
Published: (2018) -
Challenges in prevaccination screening for previous dengue infection
by: Eng Eong Ooi
Published: (2021) -
Dengue in Southeast Asia: epidemiological characteristics and strategic challenges in disease prevention Dengue no Sudeste Asiático: características epidemiológicas e desafios estratégicos na prevenção da doença
by: Eng-Eong Ooi, et al.
Published: (2009) -
Chronic sequelae complicate convalescence from both dengue and acute viral respiratory illness.
by: Shirin Kalimuddin, et al.
Published: (2022) -
Proteasome Inhibition Suppresses Dengue Virus Egress in Antibody Dependent Infection.
by: Milly M Choy, et al.
Published: (2015)